bioAffinity Technologies shares are trading higher after the company announced the Australian Patent Office accepted its patent application for a platform to detect and characterize multiple lung diseases.
bioAffinity Technologies shares are trading higher after the company announced the Australian Patent Office accepted its patent application for a platform to detect and characterize multiple lung diseases.